01.11.21

Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Treatment Roclanda

Source: Aerie Pharmaceuticals

11.13.20

Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda in the European Union

Source: Aerie Pharmaceuticals

09.24.20

Aerie Pharmaceuticals Announces Interim 90-Day Topline Data From Its 6-Month Mercury 3 Clinical Trial in Europe

Source: Aerie Pharmaceuticals

01.02.20

Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in Europe

Source: Aerie Pharmaceuticals

12.04.19

Aerie Pharmaceuticals Submits Marketing Authorization Application for Roclanda in Europe

Source: Aerie Pharmaceuticals

View more stories